129 related articles for article (PubMed ID: 38708764)
21. Mixture cure model with random effects for clustered interval-censored survival data.
Xiang L; Ma X; Yau KK
Stat Med; 2011 Apr; 30(9):995-1006. PubMed ID: 21472759
[TBL] [Abstract][Full Text] [Related]
22. Cure model analysis in cancer: an application to data from the Children's Cancer Group.
Sposto R
Stat Med; 2002 Jan; 21(2):293-312. PubMed ID: 11782066
[TBL] [Abstract][Full Text] [Related]
23. A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes.
Zhou J; Chu H; Hudgens MG; Halloran ME
Stat Med; 2016 Jan; 35(1):53-64. PubMed ID: 26194767
[TBL] [Abstract][Full Text] [Related]
24. Modeling clustered long-term survivors using marginal mixture cure model.
Niu Y; Song L; Liu Y; Peng Y
Biom J; 2018 Jul; 60(4):780-796. PubMed ID: 29733452
[TBL] [Abstract][Full Text] [Related]
25. A class of semiparametric cure models with current status data.
Diao G; Yuan A
Lifetime Data Anal; 2019 Jan; 25(1):26-51. PubMed ID: 29423775
[TBL] [Abstract][Full Text] [Related]
26. Fitting parametric cure models in R using the packages cuRe and rstpm2.
Jensen RK; Clements M; Gjærde LK; Jakobsen LH
Comput Methods Programs Biomed; 2022 Nov; 226():107125. PubMed ID: 36126436
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic checks in mixture cure models with interval-censoring.
Scolas S; Legrand C; Oulhaj A; El Ghouch A
Stat Methods Med Res; 2018 Jul; 27(7):2114-2131. PubMed ID: 27815495
[TBL] [Abstract][Full Text] [Related]
28. Clarifying selection bias in cluster randomized trials.
Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
[TBL] [Abstract][Full Text] [Related]
29. Principal stratification in causal inference.
Frangakis CE; Rubin DB
Biometrics; 2002 Mar; 58(1):21-9. PubMed ID: 11890317
[TBL] [Abstract][Full Text] [Related]
30. Gibbs sampling for long-term survival data with competing risks.
Chao EC
Biometrics; 1998 Mar; 54(1):350-66. PubMed ID: 9544528
[TBL] [Abstract][Full Text] [Related]
31. A bivariate joint frailty model with mixture framework for survival analysis of recurrent events with dependent censoring and cure fraction.
Tawiah R; McLachlan GJ; Ng SK
Biometrics; 2020 Sep; 76(3):753-766. PubMed ID: 31863594
[TBL] [Abstract][Full Text] [Related]
32. Latency function estimation under the mixture cure model when the cure status is available.
Safari WC; López-de-Ullibarri I; Jácome MA
Lifetime Data Anal; 2023 Jul; 29(3):608-627. PubMed ID: 36890338
[TBL] [Abstract][Full Text] [Related]
33. A causal inference approach to compare leukaemia treatment outcome in the absence of randomization and with dependent censoring.
Bernasconi DP; Antolini L; Rossi E; Blanco-Lopez JG; Galimberti S; Andersen PK; Valsecchi MG
Int J Epidemiol; 2022 Feb; 51(1):314-323. PubMed ID: 34368848
[TBL] [Abstract][Full Text] [Related]
34. Joint longitudinal and time-to-event cure models for the assessment of being cured.
Barbieri A; Legrand C
Stat Methods Med Res; 2020 Apr; 29(4):1256-1270. PubMed ID: 31213153
[TBL] [Abstract][Full Text] [Related]
35. Penalized likelihood estimation of a mixture cure Cox model with partly interval censoring-An application to thin melanoma.
Webb A; Ma J; Lô SN
Stat Med; 2022 Jul; 41(17):3260-3280. PubMed ID: 35474515
[TBL] [Abstract][Full Text] [Related]
36. Bayesian nonparametric generative models for causal inference with missing at random covariates.
Roy J; Lum KJ; Zeldow B; Dworkin JD; Re VL; Daniels MJ
Biometrics; 2018 Dec; 74(4):1193-1202. PubMed ID: 29579341
[TBL] [Abstract][Full Text] [Related]
37. Mean residual life cure models for right-censored data with and without length-biased sampling.
Chen CM; Chen HJ; Peng Y
Biom J; 2023 Jun; 65(5):e2100368. PubMed ID: 37068192
[TBL] [Abstract][Full Text] [Related]
38. Comparing cure rates for gemtuzumab ozogamicin plus standard chemotherapy vs standard chemotherapy alone in acute myeloid leukemia patients.
Muresan B; Mamolo C; Cappelleri JC; Mokgokong R; Palaka A; Soikkeli F; Heeg B
Future Oncol; 2021 Aug; 17(22):2883-2892. PubMed ID: 33858190
[TBL] [Abstract][Full Text] [Related]
39. A flexible cure rate model with dependent censoring and a known cure threshold.
Bernhardt PW
Stat Med; 2016 Nov; 35(25):4607-4623. PubMed ID: 27311808
[TBL] [Abstract][Full Text] [Related]
40. Causal inference in longitudinal comparative effectiveness studies with repeated measures of a continuous intermediate variable.
Wang CP; Jo B; Brown CH
Stat Med; 2014 Sep; 33(20):3509-27. PubMed ID: 24577715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
